Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: insights value based payments cms vision for 2030
… with HTA recommendations on health utility measurement for your cost-utility model? Many HTA agencies make specific … is to use quality-of-life or utility data. Australian-based preference weights are preferred for use in the scoring … as EQ-5D-3L, EQ-5D-5L and SF-6D are preferred, using a value set based on the preference of the Chinese general …
… 2024 Article written by Anne Heyes, MBA Vice President, Value and Access (Europe) RTI Health Solutions Strategic … uptake — ultimately leading to a more favorable outcome for both patients and developers. Anne Heyes shares her insights into this process, including the direction …
… respiratory market and to develop and gain market access for products to treat respiratory diseases and complications … burden of illness studies Epidemiology of disease Global Value Dossiers Literature reviews Meta-analysis studies … and psychometric evaluation Reimbursement dossiers and value communication strategies Risk management programs …
… hematology market and to develop and gain market access for products to treat hematologic diseases and complications … studies Economic burden of illness studies Global Value Dossiers Literature reviews Measurement of patient preferences for treatment options Observational studies Physician and …
… Contributed by: Anne Heyes, MBA Vice President, Head of Value & Access, Europe RTI Health Solutions United States … Act (IRA) aims to improve access to affordable treatments for people with Medicare in the United States. It allows … regulation for all new medicines will start in January 2030. This has left some wondering if line or label …
… proposed labeling claims. Our experts, particularly those based in Europe, also have significant experience liaising with the EMA to negotiate acceptability of COA-based endpoints for use in label claims, as well as guiding industry clients …
… rheumatology market and to develop and gain market access for products to treat rheumatology diseases and complications … disease Exploratory analyses of clinical trial data Global Value Dossiers Health-related quality-of-life analyses … Literature reviews Measurement of patient preferences for treatment options Observational studies Outcomes research …
… (GI) market and to develop and gain market access for products to treat GI diseases and complications arising … studies Exploratory analyses of clinical trial data Global Value Dossiers Health care resource utilization studies … physician and patient research Reimbursement and value communication strategies Risk management programs …
Navigating EU Joint Clinical Assessments and Joint Scientific Consultations From January 2025 Onward
… the final appraisal of a medicine and its recommendation for reimbursement for subsequent pricing negotiations. The aim of JCAs is to … products from January 2028, and lastly, all new drugs from 2030 onward. It also means that the clinical efficacy and …
… can help you anticipate, develop, and communicate critical value-focused information that is required by a broad range of health care decision makers, which is crucial for avoiding delays on your way to commercialization success. In today’s value-driven marketplace, you can leverage our extensive …